LUTS and sleep disorders: Emerging risk factor

Current Urology Reports

Volumn 13, Issue 6, 2012, Pages 407-412

  Cakir, Omer Onur ^a   McVary, Kevin T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BPH; Jenkins sleep scale; LUTS; Prostate; Sleep disorders

Indexed keywords

SABAL EXTRACT;

AGING; ARTICLE; BLADDER NECK STENOSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INSOMNIA; LOWER URINARY TRACT SYMPTOM; NOCTURIA; OVERACTIVE BLADDER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SABAL; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; MALE; REVIEW;

HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; RISK FACTORS; SLEEP DISORDERS;

EID: 84877134769     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-012-0281-x     Document Type: Article

References (28)

1. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006;12:S122.
2. Weiss JP, Blaivas JG. Nocturia. Curr Urol Rep. 2003;4:362.
3. • Chartier-Kastler E, Leger D, Cornet D. Prostatic hyperplasia is highly associated with nocturia and excessive sleepiness: a cross-sectional study. BMJ Open. 2012;2(3):2012. An important recent study about the relationship between BPH and excessive sleepiness.
4. Donovan JL. Measuring the impact of nocturia on quality of life. BJU Int. 1999;84 Suppl 1:21.
5. Koseoglu H, Aslan G, Ozdemir I, et al. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology. 2006;67:1188.
6. • Tikkinen KA, Johnson 2nd TM, Tammela TL, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488-96. An important population based study on the relationship between nocturia and QoL.
7. Yoshimura K, Oka Y, Kamoto T, et al. Night-time frequency, sleep disturbance and general health-related quality of life: is there a relation? Int J Urol. 2009;16:96.
8. •• Helfand BT, McVary KT, Meleth S, et al. The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial. J Urol. 2012;185:2223-8. A very important and the most recent study on the relationship between LUTS and sleep disorders.
9. Moriyama Y, Miwa K, Tanaka H, et al. Nocturia in men less than 50 years of age may be associated with obstructive sleep apnea syndrome. Urology. 2008;71:1096.
10. • Schneider T, de la Rosette JJ, Michel MC. Nocturia: a non-specific but important symptom of urological disease. Int J Urol. 2009;16:249. An important study on nocturia.
11. Weiss JP, Blaivas JG, Stember DS, et al. Nocturia in adults: etiology and classification. Neurourol Urodyn. 1998;17:467.
12. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999;84:297.
13. Cai T, Gardener N, Abraham L, et al. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int. 2006;98:799.
14. Abraham L, Hareendran A, Mills IW, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004;63:481.
15. Vaughan CP, Endeshaw Y, Nagamia Z, et al. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int. 2009;104:69.
16. Gooren L. Androgen deficiency in the aging male: benefits and risks of androgen supplementation. J Steroid Biochem Mol Biol. 2003;85:349.
17. Coyne KS, Kaplan SA, Chapple CR, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 2009;103 Suppl 3:24.
18. • Lee J, Andriole G, Avins A, et al. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials. 2009;6:628. An important study about the effects of phytotherapy on BPH.
19. • Wilt T, Ishani A, Stark G, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2009;(2):CD001423. An important study about serenoa repens and the effects on BPH.
20. Boyle P, Robertson C, Lowe F, et al. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int. 2004;93:751.
21. Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41:313.
22. Chiu YH, Silman AJ, Macfarlane GJ, et al. Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study. Pain. 2005;115:316.
23. Nasermoaddeli A, Sekine M, Kumari M, et al. Association of sleep quality and free time leisure activities in Japanese and British civil servants. J Occup Health. 2005;47:384.
24. Helfand BT, Fought A, Manvar AM, et al. Determining the Utility of Recalled Lower Urinary Tract Symptoms. Urology. 2010 Aug;76(2):442-7.
25. Jolleys JV, Donovan JL, Nanchahal K, et al. Urinary symptoms in the community: how bothersome are they? Br J Urol. 1994;74:551.
26. Kasturi S, Russell S, McVary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2006;7:288.
27. Kane CJ, Raheem OA, Bent S, et al. What do I tell patients about saw palmetto for benign prostatic hyperplasia? Urol Clin North Am. 2011;38:261-77.
28. Heland B, Lee J, McVary K, et al. Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. J Urol. (in press)